Breaking News, Collaborations & Alliances

GenScript ProBio, Eutilex Enter Cancer Collaboration

Partner on plasmid and virus process development and manufacturing for CAR-T programs

By: Contract Pharma

Contract Pharma Staff

GenScript Biotech’s contract development and manufacturing (CDMO) business, GenScript Pro-Bio, and Eutilex have entered into a collaboration on plasmid and virus process development and manufacturing for multiple CAR-T programs in order to accelerate the development of global immunotherapy.   Eutilex will use GenScript’s one-stop plasmid and virus platform for plasmid and virus process development and manufacturing in its CAR-T programs. Supported by Eutilex’s immuno-therapy technolo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters